home / stock / cntg / cntg news

CNTG News and Press, Centogene N.V. From 10/28/21

Stock Information
Company Name: Centogene N.V.
Stock Symbol: CNTG
Market: NASDAQ
Website: centogene.com
Menu
CNTG CNTG Quote CNTG Short CNTG News CNTG Articles CNTG Message Board
Get CNTG Alerts

News, Short Squeeze, Breakout and More Instantly...
CNTG - CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study

FTD is a rapidly progressing neurodegenerative disease; up to 30% of all cases worldwide caused by genetic mutations, including the progranulin gene mutation (FTD-GRN) Study will enroll and genetically test over 3,000 FTD patients at multiple sites in seven countries There are cur...
CNTG - CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN and SOUTH SAN FRANCISCO, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage Company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, and Twist Bioscience Cor...

CNTG - CENTOGENE's Ground-Breaking Family Genetic Research Published in the New England Journal of Medicine Reveals Path to Potential Cure for Structural Birth Defects

Collaborative research utilized insights gained from CENTOGENE’s rare disease-centric Bio/Databank to help analyze data of more than 20,000 families Enabled testing of successful targeted therapeutic approach that restored embryonic development in preclinical models of birth de...

CNTG - Centogene (CNTG) Presents At Global Healthcare Virtual Conference 2021 - Slideshow

The following slide deck was published by Centogene N.V. in conjunction with this event. For further details see: Centogene (CNTG) Presents At Global Healthcare Virtual Conference 2021 - Slideshow

CNTG - Centogene N.V. (CNTG) Q2 2021 Earnings Call Transcript

Image source: The Motley Fool. Centogene N.V. (NASDAQ: CNTG) Q2 2021 Earnings Call Sep 07, 2021 , 8:00 a.m. ET Lennart Streibel Continue reading For further details see: Centogene N.V. (CNTG) Q2 2021 Earnings Call Transcript

CNTG - Centogene N.V. (CNTG) CEO Andrin Oswald on Q2 2021 Results - Earnings Call Transcript

Centogene N.V. (CNTG) Q1 2021 Earnings Conference Call September 7, 2021 8:00 AM ET Company Participants Lennart Streibel - Investor Relations Andrin Oswald - Chief Executive Officer René Just - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink Catherine Sch...

CNTG - Centogene N.V. 2021 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Centogene N.V. in conjunction with their 2021 Q2 earnings call. For further details see: Centogene N.V. 2021 Q2 - Results - Earnings Call Presentation

CNTG - CENTOGENE Reports Second Quarter 2021 Financial Results

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced financial results for the second quarte...

CNTG - CENTOGENE to Announce Second Quarter 2021 Financial Results on September 7, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it will issue its financial result...

CNTG - CENTOGENE Appoints Patrice P. Denèfle as Chief Scientific Officer to Lead Its Data-Driven Approach to Reinvent Rare Disease Drug Discovery and Development

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 27, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the appointment of Dr. Patrice P. Den&#x...
Previous 10 Next 10